 |
human IgG2 anti-monoclonal antibody directed against mucosal addressin cell adhesion molecule (MAdCAM) |
|---|---|
| Trade Name | |
| Orphan Indication | Ulcerative colitis |
| USA Market Approval | USA |
| USA Designation Date | 2017-11-16 00:00:00 |
| Sponsor | Shire Human Genetic Therapies, Inc. (Shire);300 Shire Way;Lexington, Massachusetts, 02421 |
Related Access Program